Increased platelet reactivity in Klinefelter men: Something new to consider

M. N D Di Minno, D. Esposito, A. Di Minno, G. Accardo, G. Lupoli, A. Cittadini, D. Giugliano, D. Pasquali

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Patients with Klinefelter syndrome (KS) exhibit an increased cardiovascular risk, but underlying mechanisms are largely unknown. The present cross-sectional study has been conducted to evaluate platelet reactivity and the expression of platelet activation markers (8-iso-prostaglandin F2α[8-iso-PGF2α] and 11-dehydro-thromboxane-B2[11-dehydro-TXB2]) in KS patients and healthy controls. Twenty-three consecutive KS patients under testosterone replacement therapy have been included as case group and 46 age-matched healthy males recruited among hospital staff served as controls. Light transmission aggregometry was performed in both cases and controls and maximal platelet aggregation (max-A%) was defined as maximal light transmittance reached within 5 min after the addition of 0.2 or 0.4 mm arachidonic acid (AA). A ≥ 50% irreversible light transmittance (LT-50%) following platelet stimulation defined an adequate platelet aggregation and AC-50% was defined as the minimal agonist concentration needed to achieve LT-50%. The AC-50% was 0.26 mm AA for KS and 0.36 mm for controls (p <0.001). Whereas AA (0.2 mm) induced LT-50% in 69.6% of KS and in 15.2% of controls (p <0.001), the stimulation with AA (0.4 mm) determined LT-50% in all cases and controls. However, max-A% was higher in KS than in controls both after AA (0.2 mm) (65.61% vs. 46.30%, p = 0.002,) and after AA (0.4 mm) (96.43% vs. 81.04%, p <0.001). 8-iso-PGF2α and 11-dehydro-TXB2 were higher in KS than in controls (446.54 pg/mg creatinine vs. 230.00 pg/mg creatinine, p <0.001 and 1278.36 pg/mg creatinine vs. 595.08 pg/mg creatinine, p = 0.001, respectively) and AC-50% inversely correlated with 8-iso-PGF2α (ρ = -0.548, p <0.001) and with 11-dehydro-TXB2 (ρ = -0.523, p <0.001). In a linear regression model, KS independently predicted a lower AC-50% (β = -0.597, p <0.001) and higher levels of 8-iso-PGF2α (β = 0.709, p <0.001) and 11-dehydro-TXB2 (β = 0.605, p <0.001). In contrast, no correlation has been found between max-A%, testosterone and estradiol levels in KS. We observed increased platelet reactivity in KS. This might, at least in part, explain the increased thrombotic risk associated with this disease.

Original languageEnglish
Pages (from-to)876-881
Number of pages6
JournalAndrology
Volume3
Issue number5
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Klinefelter Syndrome
Blood Platelets
Arachidonic Acid
Dinoprost
Platelet Aggregation
Creatinine
Light
Testosterone
Linear Models
Platelet Activation
Estradiol
Age Groups
Cross-Sectional Studies

Keywords

  • Cardiovascular risk
  • Klinefelter syndrome
  • Platelet hyper-reactivity
  • Testosterone

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Urology

Cite this

Di Minno, M. N. D., Esposito, D., Di Minno, A., Accardo, G., Lupoli, G., Cittadini, A., ... Pasquali, D. (2015). Increased platelet reactivity in Klinefelter men: Something new to consider. Andrology, 3(5), 876-881. https://doi.org/10.1111/andr.12080

Increased platelet reactivity in Klinefelter men : Something new to consider. / Di Minno, M. N D; Esposito, D.; Di Minno, A.; Accardo, G.; Lupoli, G.; Cittadini, A.; Giugliano, D.; Pasquali, D.

In: Andrology, Vol. 3, No. 5, 01.09.2015, p. 876-881.

Research output: Contribution to journalArticle

Di Minno, MND, Esposito, D, Di Minno, A, Accardo, G, Lupoli, G, Cittadini, A, Giugliano, D & Pasquali, D 2015, 'Increased platelet reactivity in Klinefelter men: Something new to consider', Andrology, vol. 3, no. 5, pp. 876-881. https://doi.org/10.1111/andr.12080
Di Minno MND, Esposito D, Di Minno A, Accardo G, Lupoli G, Cittadini A et al. Increased platelet reactivity in Klinefelter men: Something new to consider. Andrology. 2015 Sep 1;3(5):876-881. https://doi.org/10.1111/andr.12080
Di Minno, M. N D ; Esposito, D. ; Di Minno, A. ; Accardo, G. ; Lupoli, G. ; Cittadini, A. ; Giugliano, D. ; Pasquali, D. / Increased platelet reactivity in Klinefelter men : Something new to consider. In: Andrology. 2015 ; Vol. 3, No. 5. pp. 876-881.
@article{c119c966844f46009561d40d005225ee,
title = "Increased platelet reactivity in Klinefelter men: Something new to consider",
abstract = "Patients with Klinefelter syndrome (KS) exhibit an increased cardiovascular risk, but underlying mechanisms are largely unknown. The present cross-sectional study has been conducted to evaluate platelet reactivity and the expression of platelet activation markers (8-iso-prostaglandin F2α[8-iso-PGF2α] and 11-dehydro-thromboxane-B2[11-dehydro-TXB2]) in KS patients and healthy controls. Twenty-three consecutive KS patients under testosterone replacement therapy have been included as case group and 46 age-matched healthy males recruited among hospital staff served as controls. Light transmission aggregometry was performed in both cases and controls and maximal platelet aggregation (max-A{\%}) was defined as maximal light transmittance reached within 5 min after the addition of 0.2 or 0.4 mm arachidonic acid (AA). A ≥ 50{\%} irreversible light transmittance (LT-50{\%}) following platelet stimulation defined an adequate platelet aggregation and AC-50{\%} was defined as the minimal agonist concentration needed to achieve LT-50{\%}. The AC-50{\%} was 0.26 mm AA for KS and 0.36 mm for controls (p <0.001). Whereas AA (0.2 mm) induced LT-50{\%} in 69.6{\%} of KS and in 15.2{\%} of controls (p <0.001), the stimulation with AA (0.4 mm) determined LT-50{\%} in all cases and controls. However, max-A{\%} was higher in KS than in controls both after AA (0.2 mm) (65.61{\%} vs. 46.30{\%}, p = 0.002,) and after AA (0.4 mm) (96.43{\%} vs. 81.04{\%}, p <0.001). 8-iso-PGF2α and 11-dehydro-TXB2 were higher in KS than in controls (446.54 pg/mg creatinine vs. 230.00 pg/mg creatinine, p <0.001 and 1278.36 pg/mg creatinine vs. 595.08 pg/mg creatinine, p = 0.001, respectively) and AC-50{\%} inversely correlated with 8-iso-PGF2α (ρ = -0.548, p <0.001) and with 11-dehydro-TXB2 (ρ = -0.523, p <0.001). In a linear regression model, KS independently predicted a lower AC-50{\%} (β = -0.597, p <0.001) and higher levels of 8-iso-PGF2α (β = 0.709, p <0.001) and 11-dehydro-TXB2 (β = 0.605, p <0.001). In contrast, no correlation has been found between max-A{\%}, testosterone and estradiol levels in KS. We observed increased platelet reactivity in KS. This might, at least in part, explain the increased thrombotic risk associated with this disease.",
keywords = "Cardiovascular risk, Klinefelter syndrome, Platelet hyper-reactivity, Testosterone",
author = "{Di Minno}, {M. N D} and D. Esposito and {Di Minno}, A. and G. Accardo and G. Lupoli and A. Cittadini and D. Giugliano and D. Pasquali",
year = "2015",
month = "9",
day = "1",
doi = "10.1111/andr.12080",
language = "English",
volume = "3",
pages = "876--881",
journal = "Andrology",
issn = "2047-2919",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Increased platelet reactivity in Klinefelter men

T2 - Something new to consider

AU - Di Minno, M. N D

AU - Esposito, D.

AU - Di Minno, A.

AU - Accardo, G.

AU - Lupoli, G.

AU - Cittadini, A.

AU - Giugliano, D.

AU - Pasquali, D.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Patients with Klinefelter syndrome (KS) exhibit an increased cardiovascular risk, but underlying mechanisms are largely unknown. The present cross-sectional study has been conducted to evaluate platelet reactivity and the expression of platelet activation markers (8-iso-prostaglandin F2α[8-iso-PGF2α] and 11-dehydro-thromboxane-B2[11-dehydro-TXB2]) in KS patients and healthy controls. Twenty-three consecutive KS patients under testosterone replacement therapy have been included as case group and 46 age-matched healthy males recruited among hospital staff served as controls. Light transmission aggregometry was performed in both cases and controls and maximal platelet aggregation (max-A%) was defined as maximal light transmittance reached within 5 min after the addition of 0.2 or 0.4 mm arachidonic acid (AA). A ≥ 50% irreversible light transmittance (LT-50%) following platelet stimulation defined an adequate platelet aggregation and AC-50% was defined as the minimal agonist concentration needed to achieve LT-50%. The AC-50% was 0.26 mm AA for KS and 0.36 mm for controls (p <0.001). Whereas AA (0.2 mm) induced LT-50% in 69.6% of KS and in 15.2% of controls (p <0.001), the stimulation with AA (0.4 mm) determined LT-50% in all cases and controls. However, max-A% was higher in KS than in controls both after AA (0.2 mm) (65.61% vs. 46.30%, p = 0.002,) and after AA (0.4 mm) (96.43% vs. 81.04%, p <0.001). 8-iso-PGF2α and 11-dehydro-TXB2 were higher in KS than in controls (446.54 pg/mg creatinine vs. 230.00 pg/mg creatinine, p <0.001 and 1278.36 pg/mg creatinine vs. 595.08 pg/mg creatinine, p = 0.001, respectively) and AC-50% inversely correlated with 8-iso-PGF2α (ρ = -0.548, p <0.001) and with 11-dehydro-TXB2 (ρ = -0.523, p <0.001). In a linear regression model, KS independently predicted a lower AC-50% (β = -0.597, p <0.001) and higher levels of 8-iso-PGF2α (β = 0.709, p <0.001) and 11-dehydro-TXB2 (β = 0.605, p <0.001). In contrast, no correlation has been found between max-A%, testosterone and estradiol levels in KS. We observed increased platelet reactivity in KS. This might, at least in part, explain the increased thrombotic risk associated with this disease.

AB - Patients with Klinefelter syndrome (KS) exhibit an increased cardiovascular risk, but underlying mechanisms are largely unknown. The present cross-sectional study has been conducted to evaluate platelet reactivity and the expression of platelet activation markers (8-iso-prostaglandin F2α[8-iso-PGF2α] and 11-dehydro-thromboxane-B2[11-dehydro-TXB2]) in KS patients and healthy controls. Twenty-three consecutive KS patients under testosterone replacement therapy have been included as case group and 46 age-matched healthy males recruited among hospital staff served as controls. Light transmission aggregometry was performed in both cases and controls and maximal platelet aggregation (max-A%) was defined as maximal light transmittance reached within 5 min after the addition of 0.2 or 0.4 mm arachidonic acid (AA). A ≥ 50% irreversible light transmittance (LT-50%) following platelet stimulation defined an adequate platelet aggregation and AC-50% was defined as the minimal agonist concentration needed to achieve LT-50%. The AC-50% was 0.26 mm AA for KS and 0.36 mm for controls (p <0.001). Whereas AA (0.2 mm) induced LT-50% in 69.6% of KS and in 15.2% of controls (p <0.001), the stimulation with AA (0.4 mm) determined LT-50% in all cases and controls. However, max-A% was higher in KS than in controls both after AA (0.2 mm) (65.61% vs. 46.30%, p = 0.002,) and after AA (0.4 mm) (96.43% vs. 81.04%, p <0.001). 8-iso-PGF2α and 11-dehydro-TXB2 were higher in KS than in controls (446.54 pg/mg creatinine vs. 230.00 pg/mg creatinine, p <0.001 and 1278.36 pg/mg creatinine vs. 595.08 pg/mg creatinine, p = 0.001, respectively) and AC-50% inversely correlated with 8-iso-PGF2α (ρ = -0.548, p <0.001) and with 11-dehydro-TXB2 (ρ = -0.523, p <0.001). In a linear regression model, KS independently predicted a lower AC-50% (β = -0.597, p <0.001) and higher levels of 8-iso-PGF2α (β = 0.709, p <0.001) and 11-dehydro-TXB2 (β = 0.605, p <0.001). In contrast, no correlation has been found between max-A%, testosterone and estradiol levels in KS. We observed increased platelet reactivity in KS. This might, at least in part, explain the increased thrombotic risk associated with this disease.

KW - Cardiovascular risk

KW - Klinefelter syndrome

KW - Platelet hyper-reactivity

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=84942295999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942295999&partnerID=8YFLogxK

U2 - 10.1111/andr.12080

DO - 10.1111/andr.12080

M3 - Article

C2 - 26216452

AN - SCOPUS:84942295999

VL - 3

SP - 876

EP - 881

JO - Andrology

JF - Andrology

SN - 2047-2919

IS - 5

ER -